A leading epidemiologist has attacked Swedish research that looked at inequalities in patients' access to cancer drugs across Europe and the world. In a commentary published in the September issue of the cancer journal, Annals of Oncology, Professor Mich ...
Source:
European Society for Medical Oncology
Wednesday, August 29, 2007